Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion type Assertion NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_head.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion description "[Here we report a secondary reduction in calpain 3 expression in eight out of 16 patients with a primary dysferlinopathy and clinical features characteristic of limb girdle muscular dystrophy type 2B or Miyoshi myopathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_provenance.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion evidence source_evidence_literature NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_provenance.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion SIO_000772 11053681 NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_provenance.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion wasDerivedFrom befree-20140225 NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_provenance.
- NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_assertion wasGeneratedBy ECO_0000203 NP167515.RAVuZ_FfDsG-qWi_Kduao9lNOT3hEjfYj-6XVj5P2xUw0130_provenance.